Storia in 2 fonti

Alkem rolls out single-shot pre-filled syringes of semaglutide

Alkem launches affordable semaglutide pre-filled syringes for diabetes and obesity, expanding treatment options with multiple dose strengths.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo15 h fa

Alkem rolls out single-shot pre-filled syringes of semaglutide

Alkem launches affordable semaglutide pre-filled syringes for diabetes and obesity, expanding treatment options with multiple dose strengths.

originale

economictimes.indiatimes.com21 h fa

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss

Alkem launched India's first semaglutide syringes at Rs 350, competing in a market projected to grow 5x by 2030. Patent expiry attracted 40+ competitors within months, compressing prices from Rs 1,290 to Rs 350—a consolidation dynamic IT leaders face in SaaS maturation.

Leggi questa versione →

Timeline cronologica

martedì 2 giugno 2026·economictimes.indiatimes.com
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management.…
martedì 2 giugno 2026·thehindubusinessline.com
Alkem rolls out single-shot pre-filled syringes of semaglutide
Alkem launches affordable semaglutide pre-filled syringes for diabetes and obesity, expanding treatment options with multiple dose strengths.